NCT06211595View on ClinicalTrials.gov

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

December 6, 2023

Study Completion Date

November 30, 2024

Conditions
Obstructive Hypertrophic Cardiomyopathy
Interventions
DEVICE

DragonFire Transcatheter Myocardial Radiofrequency Ablation System

The patients with hypertrophic obstructive cardiomyopathy were treated with a transcatheter myocardial radiofrequency ablation system and its guiding system under the guidance of echocardiography

Trial Locations (1)

Unknown

The Second Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Hangzhou Valgen Medtech Co., Ltd

INDUSTRY